Clinical Trial Update: Atrial Fibrillation Management in Congestive Heart Failure With Ablation [NA]

View source ↗

Summary

The Abbott Medical Devices-sponsored trial evaluating ablation-based management of persistent atrial fibrillation in patients with heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure

Snippet

Sponsor: Abbott Medical Devices | Conditions: Persistent Atrial Fibrillation, Heart Failure | NA | Status: COMPLETED